

Cash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities


UK Shareholder Meetings Calendar - Next 7 Days


IN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes


IN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover


(Sharecast News) - Pharmaceutical company Motif Bio saw its shares suspended from trading on Wednesday in order to satisfy AIM rules.


CORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline


IN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline


UK TRADING UPDATE SUMMARY: Fuller Smith & Turner Gets GBP100 Million